NIEL, Belgium, May 31, 2018 /PRNewswire/ -- eTheRNA immunotherapies, a clinical-stage company developing novel cancer immunotherapies based on its unique mRNA-based TriMix platform, announces that Acting CEO Marc Dechamps will present an overview of the Company, its technology and...
from PR Newswire: //https://ift.tt/2xtsyMb
No comments:
Post a Comment